when to buy a new mattress mattress maker says

When To Buy a New Mattress (Mattress Maker Says)

Costco has released a new ad, touting its new mattress that it says will “revolutionize the way we store, care for and sleep.”

“The Cool Gel, the best hybrid mattress on the market, delivers superior comfort, long-lasting durability and the ability to sleep better,” the ad says.

The ad, which was first spotted by Wired, goes on to say that it will “reduce your COVID-19 risk, as well as your overall COVID risk.”

While the ads claims that the mattress is “made with all-natural, organic ingredients,” the brand also said it uses “eco-friendly, 100% organic cotton to minimize waste.”

The ads also claim that the Cool Gel mattress has “an improved fit, improved feel and better support than traditional mattresses.”

In a statement, Costco said it has tested the Cool Gels for a year and found that “the mattress has performed exceptionally well and we have no plans to discontinue our Cool Gel product line.”

The company also said that it is currently reviewing consumer feedback.

According to Wired, Cool Gel has “received mixed reviews” on its site, with a few users saying it feels “too soft.”

Cool Gel was launched by Amazon in September 2016 and is the second-most popular mattress on Amazon.

The company says that Cool Gel “features innovative design, patented Cool Gel technology, and a premium price.”

The Cool Gel is the only Cool Gel that does not use “sugar” as a sweetener.

The Cool Gel is made of “sulfur dioxide,” a substance that has been linked to the development of COVIDs.

It is also made of polyethylene, which is more than 30 percent heavier than Styrofoam, according to Amazon.

(The Styrocell foam used in Cool Gel can weigh between 70 and 100 pounds.)

According to the US Centers for Disease Control and Prevention, COVID sufferers can spend up to $6,000 per year in the United States on the costs of treating COVID related symptoms.

The cost of treatment is estimated at $60,000 to $70,000 a year.

The Centers for Medicare and Medicaid Services has estimated that, on average, $6.8 billion is spent on COVID treatment in the U.S. each year.

In the last 10 years, more than $8.5 billion in COVID treatments have been paid for in the US.

The CDC estimates that COVID cases have been falling in the last decade and that COV-19 deaths have declined by more than 90 percent.

The COVID Centers for Healthcare Improvement has also found that COVR infections have dropped by more a quarter since 1999, and there have been fewer deaths from COVID during the past decade.

However, there has been no significant decrease in cases or deaths from other infections.